Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Candid to Develop China-Sourced TCEs for Autoimmune Diseases

publication date: Sep 9, 2024

Candid Therapeutics broke out of stealth mode today with a plan to develop T Cell engagers (TCEs) to treat autoimmune diseases. Candid believes that a specific subset of immune cells, B lymphocytes, plays a pivotal role in autoimmune diseases. The San Diego startup was created by acquiring two other companies, Vignette Bio and TRC 2004, each of which contributed a B lymphocyte candidate they had in-licensed from a Chinese biotech. The company expects the two candidates offer a “once in a lifetime opportunity” to develop novel therapies for autoimmune diseases such as rheumatoid arthritis and myasthenia gravis. Both candidates are in trials for cancer indications. More details....

Share this with colleagues:  



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here